Therapeutic Targeting of Ependymoma As Informed By Oncogenic Enhancer Profiling
— Categories: Ependymoma Research Articles Posted on January 9, 2018
Scientists have now developed a molecular approach that may open new treatment prospects for ependymoma.
The genetic causes for ependymomas development are largely unknown and there are no targeted treatments to date. In the quest for novel therapeutic approaches in the treatment of ependymoma, scientists began testing an alternative approach. They took a closer look at so-called enhancers, regions of the genome that regulate the activity of genes. They were able to demonstrate that these enhancer elements regulate molecules that are involved in key cellular processes and may therefore be used as targets for targeted therapies. Info provided by: German Cancer Research Center.